Literature DB >> 24349868

Neuropsychological effects of deep brain stimulation for Parkinson's disease.

Ali Harati1, Thomas Müller2.   

Abstract

BACKGROUND: Putative changes of cognition after deep brain stimulation (DBS) in patients with Parkinson's disease (PD) are a matter of debate. The aim of this study was to assess cognitive abilities before and following bilateral subthalamic nucleus (STN) DBS and to review the available literature.
METHODS: Twenty patients underwent bilateral DBS of the STN. Cognitive skills were assessed in a standardized fashion before and at least at 12 months after the surgical intervention.
RESULTS: There was a significant decline of both semantic and phonematic verbal fluency and a mild trend for a deterioration of verbal memory after DBS. Mood, general cognitive screening, and visospatial abilities remained unchanged.
CONCLUSION: STN DBS in the treatment of PD has resulted in a significant reduction of motor symptoms and improved independence and quality of life in appropriately selected patients. However, it may have isolatable effects on verbal fluency and related function. Case series in the literature reported similar findings. Potential candidates for DBS should be counseled about the risk of mild cognitive declines.

Entities:  

Keywords:  Cognitive decline; Parkinson's disease; deep brain stimulation; memory; subthalamic nucleus; verbal fluency

Year:  2013        PMID: 24349868      PMCID: PMC3858804          DOI: 10.4103/2152-7806.121637

Source DB:  PubMed          Journal:  Surg Neurol Int        ISSN: 2152-7806


INTRODUCTION

Parkinson's disease (PD) is a common neurodegenerative motor disorder, clinically characterized by the progressive impairment of motor function and associated cognitive decline.[21] Deep brain stimulation (DBS) of the bilateral subthalamic nuclei (STN) treatment was proven to be surgically safe in well-selected candidates. DBS improves dopamine sensitive symptoms and dyskinesia and allows for reduced drug doses.[58121830] However, short- and long-term investigations of STN DBS in PD patients yielded variable findings regarding the nature and extent of cognitive changes after surgery. Therefore cognitive changes and the predictors for such changes are still a matter of debate.[368910121417192832373842434448495152] We had already demonstrated an improved performance of executive functions, complex motion sequences, and complex reaction time shortly after DBS.[13] The aim of our present study was to assess cognitive outcome in PD patients by a standardized performance of a neuropsychological test battery following STN DBS after an interval of at least several months lasting interval.

PATIENTS AND METHODS

Patients

20 PD patients (13 men) participated in this trial. They received bilateral DBS of the STN. The selection criteria were clinically diagnosed PD, severe levodopa-related motor complications despite prior optimal adjustment of antiparkinsonian medication, no surgical contraindications, no dementia or major ongoing psychiatric illness and no other neurological disorders. The characteristics of the patients are summarized in Table 1.
Table 1

Patient characteristics

Patient characteristics

Surgical techniques

The procedures were staged in all patients with implantation of bilateral STN electrodes in one session and implantation of the pulse generators in a second session 3-5 days later. A Leksell stereotactic head frame (Elekta Instruments, Stockholm, Sweden) was placed. The dorsolateral (sensorimotor) portion of the STN was localized using a proportional geometric scheme based on the distance between the anterior commissure and the posterior commissure, as well as the location of the midcommisural point. The electrodes were implanted under local anesthesia during a single operative session, using a combined approach of intraoperative recording and stimulation. The electrode position was controlled either by postoperative computed tomography (CT) or magnet resonance imaging (MRI). The definitive quadripolar electrodes (model 3389; Medtronic) were connected to a subcutaneous programmable pulse generator (Kinetra; Medtronic) in the subclavicular area in a second operative session. Electrical parameters (pulse width, frequency, and voltage) were adjusted progressively using an electromagnetic programmer (7532 neurological programmer; Medtronic).

Cognitive and behavioral assessment

Cognitive assessment was carried out with an extensive neuropsychological test battery. It included: Cognitive screening by the Mini Mental State Examination (MMSE)[16] and the Parkinson Neuropsychometric Dementia Assessment (PANDA)[23] Verbal memory with a German version of the Rey Auditory Verbal Learning Test (verbal memory test [VLMT])[33] and the verbal digit span forward and backward (German version of Wechsler memory scale-Revised [WMS-R]) Determination of amnestic disorders (Berlin amnesia test [BAT])[31] Investigation of visospatial abilities by the Clock drawing test[41] and the Leistungsprüfsystem (LPS) subtests 3 and 7[20] Performance of language phonological and semantic verbal fluency (“Regensburg verbal fluency test” [RWT])[2] Execution of the Becks Depression Inventory (BDI).[4] The raw scores were assessed for each patient. The raw scores for WMS-R, VLMT, RWT, BAT, and LPS were then adjusted for age-matched percentile-ranges.

Design

Cognitive assessment and a clinical interview, aimed at detecting the presence of behavioral abnormalities or psychiatric disorders, were performed preoperatively (during the week preceding electrode implantation) and postoperatively between 12 and 18 months after implantation. All cognitive and behavioral assessments before and after surgery were performed while the patients were on an antiparkinsonian medication. Postoperative cognitive and behavioral assessments were performed with stimulators turned on.

Statistical analysis

Statistical analyses were performed using the Statistical Package for the Social Sciences (SPSS version 13.0). The Wilcoxon rank sum test was applied for comparison between the mean scores preoperatively and at the postoperative assessment. A level of P < 0.05 was considered significant.

Ethics

Written informed consent was obtained from each subject. The local ethics committee of the university approved this study.

RESULTS

There was a worsening of verbal fluency and verbal digit span after DBS. Verbal memory declined compared with preoperative scores and deteriorated in two out of six items. The general cognitive screening and visospatial abilities remained unchanged. Mood was not altered [Table 2]. No serious adverse events (e.g., hemorrhage, infection, or infarction) occurred during surgery. Postoperative imaging revealed no dislocation of the electrodes.
Table 2

Neuropsychological assessment results

Neuropsychological assessment results

DISCUSSION

Our results and the most consistent findings from the literature [Table 3] revealed declines in verbal fluency. Additionally, our results also confirmed previous results, which demonstrated more decline of verbal memory relative to nonverbal memory.[19] Otherwise, executive functions and visospatial abilities were less affected following STN DBS.
Table 3

Review of case series regarding cognitive decline after STN DBS for PD

Review of case series regarding cognitive decline after STN DBS for PD The variable frequencies of cognitive decline after STN DBS in the literature were caused by different ascertainment methods, patient selection criteria, operative techniques, and pre- and postoperative patient management strategies. Studies using formal and substantial neuropsychological evaluation were more likely to find changes than studies using undefined methods or simple cognitive screening instruments such as the MMSE. Despite use of different assessment tools, STN DBS in most series was associated with decline of verbal fluency. Performance on verbal fluency might be disrupted in PD and consecutively predict incipient dementia.[2150] Otherwise, the finding that STN DBS patients declined in verbal fluency and related functions more than in other cognitive tasks might reflect a different mechanism underlying cognitive deterioration following surgery. Declines in verbal fluency were usually associated with left-sided DBS.[5354] In a positron emission tomography (PET) study STN stimulation resulted in decreased activation of the inferior frontal and temporal cortex in the left cerebral hemisphere, resulting in decreased verbal fluency.[40] The effects of STN DBS might be attributable to the electrical stimulation of specific structures or inhibition of over activity in the thalamic region. However, since the decline in verbal fluency was mostly detected shortly after surgery, it might be due to surgical micro lesions affecting cortical-basal circuits involved in word retrieval processes.[454647] Several studies assessed language function in PD patients following STN DBS on and off stimulation. With the exception of two, all studies failed to observe a significant improvement or decline in verbal fluency in the on-stimulation compared with the off-stimulation condition.[2237] In conclusion, STN DBS independently affects verbal and nonverbal cognitive function. STN DBS in the treatment of PD has resulted in a significant reduction of motor symptoms and improved independence and quality of life for most carefully selected patients. This procedure is associated with some risk for cognitive side effects beyond the expected rate of usual surgical complications such as hemorrhage or infection. The neuropsychological assessment must be considered essential to minimize such risks and to further our understanding of the underlying neurobiology and neuropsychological impact of these treatments.
  52 in total

1.  Neuropsychological changes between "off" and "on" STN or GPi stimulation in Parkinson's disease.

Authors:  B Pillon; C Ardouin; P Damier; P Krack; J L Houeto; H Klinger; A M Bonnet; P Pollak; A L Benabid; Y Agid
Journal:  Neurology       Date:  2000-08-08       Impact factor: 9.910

2.  Chronic deep brain stimulation of the subthalamic nucleus for Parkinson's disease: effects on cognition, mood, anxiety and personality traits.

Authors:  L Castelli; P Perozzo; M Zibetti; B Crivelli; U Morabito; M Lanotte; F Cossa; B Bergamasco; L Lopiano
Journal:  Eur Neurol       Date:  2006-05-08       Impact factor: 1.710

3.  The impact of deep brain stimulation on executive function in Parkinson's disease.

Authors:  M Jahanshahi; C M Ardouin; R G Brown; J C Rothwell; J Obeso; A Albanese; M C Rodriguez-Oroz; E Moro; A L Benabid; P Pollak; P Limousin-Dowsey
Journal:  Brain       Date:  2000-06       Impact factor: 13.501

4.  Changes in cognitive-emotional and physiological symptoms of depression following STN-DBS for the treatment of Parkinson's disease.

Authors:  A M Strutt; R Simpson; J Jankovic; M K York
Journal:  Eur J Neurol       Date:  2011-06-11       Impact factor: 6.089

5.  The Mini-Mental State Examination.

Authors:  M F Folstein; L N Robins; J E Helzer
Journal:  Arch Gen Psychiatry       Date:  1983-07

6.  Motor and cognitive outcome in patients with Parkinson's disease 8 years after subthalamic implants.

Authors:  Alfonso Fasano; Luigi M Romito; Antonio Daniele; Carla Piano; Massimiliano Zinno; Anna Rita Bentivoglio; Alberto Albanese
Journal:  Brain       Date:  2010-09       Impact factor: 13.501

7.  Long-term cognitive profile and incidence of dementia after STN-DBS in Parkinson's disease.

Authors:  Selma Aybek; Aline Gronchi-Perrin; Alexandre Berney; Sabina Catalano Chiuvé; Jean-Guy Villemure; Pierre R Burkhard; François J G Vingerhoets
Journal:  Mov Disord       Date:  2007-05-15       Impact factor: 10.338

8.  Apathy and verbal fluency in STN-stimulated PD patients. An observational follow-up study.

Authors:  L Castelli; M Lanotte; M Zibetti; M Caglio; L Rizzi; A Ducati; B Bergamasco; L Lopiano
Journal:  J Neurol       Date:  2007-04-11       Impact factor: 4.849

9.  Deep brain stimulation and cognitive decline in Parkinson's disease: a clinical review.

Authors:  João Massano; Carolina Garrett
Journal:  Front Neurol       Date:  2012-04-26       Impact factor: 4.003

10.  Distinct roles of dopamine and subthalamic nucleus in learning and probabilistic decision making.

Authors:  Elizabeth J Coulthard; Rafal Bogacz; Shazia Javed; Lucy K Mooney; Gillian Murphy; Sophie Keeley; Alan L Whone
Journal:  Brain       Date:  2012-10-31       Impact factor: 13.501

View more
  2 in total

1.  Deep Brain Stimulation Frequency of the Subthalamic Nucleus Affects Phonemic and Action Fluency in Parkinson's Disease.

Authors:  Valéria de Carvalho Fagundes; Carlos R M Rieder; Aline Nunes da Cruz; Bárbara Costa Beber; Mirna Wetters Portuguez
Journal:  Parkinsons Dis       Date:  2016-12-05

2.  Deep Brain Stimulation of the Subthalamic Nucleus Improves Lexical Switching in Parkinsons Disease Patients.

Authors:  Isabelle Vonberg; Felicitas Ehlen; Ortwin Fromm; Andrea A Kühn; Fabian Klostermann
Journal:  PLoS One       Date:  2016-08-30       Impact factor: 3.240

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.